Aegean Conferences

4th International Conference on Tissue Repair, Regeneration, and Fibrosis

Authors List

Important: The program online is copyrighted to each author and should not be copied and pasted!

Author	Abstracts
Amador Cristian	*Attenuation of Fibrosis in Folic Acid-Induced Kidney Injury by Endogenous Gal-8*
Abdelnabi Mohamed	*The dual role of neutrophils during liver injury*
Abecasis Bernardo	*Modeling cardiac fibrosis in vitro: impact of monocyte-derived macrophages on cardiac fibroblast activation*
Adler Miri	*Cold and hot fibrosis define clinically distinct cardiac injuries*
Akutsu Fumie	*Construction and performance evaluation of CTGF measurement system for IPF biomarker candidate*
Alon Uri	*Cold and hot fibrosis define clinically distinct cardiac injuries*
Andersen Birgitte	*Macrophage and hepatic stellate cell phenotypes are affected by longitudinal treatment with Zalfermin in a model of Metabolic Dysfunction-Associated Steatohepatitis*
Arez Francisca	*Modeling cardiac fibrosis in vitro: impact of monocyte-derived macrophages on cardiac fibroblast activation*
Ariel Amiram	*The BiST of Burden: Harnessing biased STING agonists to enhance the resolution of inflammation and limit tissue fibrosis*
Arondal Wendy	*Role and Therapeutic Potential of the Long Non-Coding RNA DNM3OS in Liver Fibrosis*
Asgharpour Sara	*THBS1’s mediating role in cell-cell communication routes of lung fibrosis and regeneration*
Atit Radhika	*Starts and stops: Adipocytes in tissue repair and fibrosis*
Baranes Danny	*In Vitro Liver Tissue Engineering with Coralline Biomaterial*
Barker Thomas H.	*Mechanically regulated transcription factors balance between regenerative and fibrotic cell memory*
Barron Alexander	*Myeloid cells contribute to bystander CD8 T-cell accumulation in MASH and are sufficient for fibrosis* *Leveraging Single Cell Genomics to Resolve Macrophage Heterogeneity across Tissue and Disease: Mapping in vitro to in vivo Profiles* *Fab5 macrophage expression of GPNMB promote fibrosis across organs*
Bearzi Pietro	*Characterization of monocytes in systemic sclerosis: linking gene signatures to skin fibrosis trajectories*
Becker Mike	*Characterization of monocytes in systemic sclerosis: linking gene signatures to skin fibrosis trajectories*
Ben Jashar Nofar	*The BiST of Burden: Harnessing biased STING agonists to enhance the resolution of inflammation and limit tissue fibrosis*
Borengasser Aiwei	*Epigenetic control of extracellular matrix genes by histone acetyltransferase p300*
borthwick lee	*Fab5 macrophage expression of GPNMB promote fibrosis across organs* *Using human tissue models to illuminate the biology of fibrosis and unlock new drug targets*
Boukrout Nihad	*Role and Therapeutic Potential of the Long Non-Coding RNA DNM3OS in Liver Fibrosis*
Bound Kathryn	*Leveraging Single Cell Genomics to Resolve Macrophage Heterogeneity across Tissue and Disease: Mapping in vitro to in vivo Profiles* *Fab5 macrophage expression of GPNMB promote fibrosis across organs* *Myeloid cells contribute to bystander CD8 T-cell accumulation in MASH and are sufficient for fibrosis*
Brenner David	*Macrophage Heterogeneity during NASH Regression Unveils Multifaceted TREM2 Dependent Mechanisms that Facilitate NASH and Fibrosis Resolution*
Brito Catarina	*Modeling cardiac fibrosis in vitro: impact of monocyte-derived macrophages on cardiac fibroblast activation*
Brys Reginald	*AGMB-101, a full agonistic antibody of MET, achieves deep suppression of liver fibrosis through a pleiotropic mechanism of action*
Buckley Christopher	*A therapeutic cell atlas focusing on fibroblasts*
Budas Grant	*Combination strategies for MASH* *Combination strategies for MASH*
Bürki Kristina	*Characterization of monocytes in systemic sclerosis: linking gene signatures to skin fibrosis trajectories*
calvo ibai	*PPARγ Repression Of Renal Tubular Epithelial Cell dysmetabolism to Treat Fibrosis*
Cauffiez Christelle	*Role and Therapeutic Potential of the Long Non-Coding RNA DNM3OS in Liver Fibrosis*
Caves Elizabeth	*Starts and stops: Adipocytes in tissue repair and fibrosis*
Cazzanti Manuela	*AGMB-101, a full agonistic antibody of MET, achieves deep suppression of liver fibrosis through a pleiotropic mechanism of action*
Chatzigeorgiou Antonios	*The endothelial-specific receptor Robo4 protects against metabolic dysfunction-associated steatotic liver disease and progression to liver fibrosis*
Chen Xiao	*Myeloid cells contribute to bystander CD8 T-cell accumulation in MASH and are sufficient for fibrosis*
Cheroutre Hilde	*Targeting Fibrosis to Change Cancer Outcomes*
Christensen Stephen	*Leveraging Single Cell Genomics to Resolve Macrophage Heterogeneity across Tissue and Disease: Mapping in vitro to in vivo Profiles* *Fab5 macrophage expression of GPNMB promote fibrosis across organs* *Myeloid cells contribute to bystander CD8 T-cell accumulation in MASH and are sufficient for fibrosis*
Coelho Pedro	*Modeling cardiac fibrosis in vitro: impact of monocyte-derived macrophages on cardiac fibroblast activation*
Croft Michael	*Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis*
De Saurav	*Leveraging Single Cell Genomics to Resolve Macrophage Heterogeneity across Tissue and Disease: Mapping in vitro to in vivo Profiles* *Fab5 macrophage expression of GPNMB promote fibrosis across organs*
de la Peña Adely	*Attenuation of Fibrosis in Folic Acid-Induced Kidney Injury by Endogenous Gal-8*
De Langhe Stijn	*Cell competition drives bronchiolization and pulmonary fibrosis.*
Dell Garrison	*Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis* *Targeting Fibrosis to Change Cancer Outcomes*
Dermit Maria	*Macrophage and hepatic stellate cell phenotypes are affected by longitudinal treatment with Zalfermin in a model of Metabolic Dysfunction-Associated Steatohepatitis*
Diniz Cláudia	*Modeling cardiac fibrosis in vitro: impact of monocyte-derived macrophages on cardiac fibroblast activation*
Dion Jessica	*The dual role of neutrophils during liver injury*
Distler Oliver	*Characterization of monocytes in systemic sclerosis: linking gene signatures to skin fibrosis trajectories*
Doerflein Hailey	*Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis* *Targeting Fibrosis to Change Cancer Outcomes*
Doubkova Martina	*Alleviating fibrosis in the stiff, contracted tissue of clubfoot: A way to facilitate faster corrective therapy in relapsed patients?* *Proteomic comparison of contracted tissues of Dupuytren's disease with palmar fascia*
Dower Ken	*Fab5 macrophage expression of GPNMB promote fibrosis across organs* *Myeloid cells contribute to bystander CD8 T-cell accumulation in MASH and are sufficient for fibrosis* *Leveraging Single Cell Genomics to Resolve Macrophage Heterogeneity across Tissue and Disease: Mapping in vitro to in vivo Profiles*
Dreier Torsten	*AGMB-101, a full agonistic antibody of MET, achieves deep suppression of liver fibrosis through a pleiotropic mechanism of action*
Drzewiecka Ewa	*Involvement of interleukin 17 in mare endometrial fibrosis*
Eckhardt Adam	*Alleviating fibrosis in the stiff, contracted tissue of clubfoot: A way to facilitate faster corrective therapy in relapsed patients?* *Proteomic comparison of contracted tissues of Dupuytren's disease with palmar fascia* *3D scaffold-based in vitro model of Dupuytren´s disease*
Ehrbar Martin	*3DPROFIB: an in vitro 3D assay in synthetic hydrogels to quantify extracellular matrix remodeling in fibrosis*
Eickelberg Oliver	*The role of B cells and plasma cells in the pathogenesis of fibrosis*
Endo Koki	*Construction and performance evaluation of CTGF measurement system for IPF biomarker candidate*
Espinoza Sofía	*Attenuation of Fibrosis in Folic Acid-Induced Kidney Injury by Endogenous Gal-8*
Fabre Thomas	*Myeloid cells contribute to bystander CD8 T-cell accumulation in MASH and are sufficient for fibrosis* *Leveraging Single Cell Genomics to Resolve Macrophage Heterogeneity across Tissue and Disease: Mapping in vitro to in vivo Profiles* *Fab5 macrophage expression of GPNMB promote fibrosis across organs*
Feghali-Bostwick Carol	*Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis*
Fellah Sandy	*Role and Therapeutic Potential of the Long Non-Coding RNA DNM3OS in Liver Fibrosis*
Fernandez Jose Andres	*PPARγ Repression Of Renal Tubular Epithelial Cell dysmetabolism to Treat Fibrosis*
Ferreira Susana	*Modeling cardiac fibrosis in vitro: impact of monocyte-derived macrophages on cardiac fibroblast activation*
Ferreira-Dias Graca	*How Th2 specific cytokines: interleukin (IL)-4 and IL-13 affect cellular metabolism and reactive oxygen species production in mare endometrial fibroblasts?* *Understanding the effect of hypoxia on the interactions between endometrial fibroblasts and macrophages in equine endometrosis – in vitro study* *Involvement of interleukin 17 in mare endometrial fibrosis*
Feuerhake Teo	*Attenuation of Fibrosis in Folic Acid-Induced Kidney Injury by Endogenous Gal-8*
Filova Elena	*Alleviating fibrosis in the stiff, contracted tissue of clubfoot: A way to facilitate faster corrective therapy in relapsed patients?* *3D scaffold-based in vitro model of Dupuytren´s disease*
Finger Anna	*Macrophage and hepatic stellate cell phenotypes are affected by longitudinal treatment with Zalfermin in a model of Metabolic Dysfunction-Associated Steatohepatitis*
Flores Molina Manuel	*The dual role of neutrophils during liver injury*
Forni Maria	*Starts and stops: Adipocytes in tissue repair and fibrosis*
Galili Uri	*Regeneration in Mice of Injured Skin, Heart, and Spinal Cord by α-Gal Nanoparticles Recapitulates Regeneration in Amphibians*
Garcia Iana	*Leveraging Single Cell Genomics to Resolve Macrophage Heterogeneity across Tissue and Disease: Mapping in vitro to in vivo Profiles*
Genovese Federica	*3DPROFIB: an in vitro 3D assay in synthetic hydrogels to quantify extracellular matrix remodeling in fibrosis*
Ghastine Andrew	*Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis*
Giannousi Eirini	*The endothelial-specific receptor Robo4 protects against metabolic dysfunction-associated steatotic liver disease and progression to liver fibrosis*
Glowacki François	*Role and Therapeutic Potential of the Long Non-Coding RNA DNM3OS in Liver Fibrosis*
Gonzalez Alfonso	*Attenuation of Fibrosis in Folic Acid-Induced Kidney Injury by Endogenous Gal-8*
Guilliams Martin	*Deciphering stellate cell quiescence program*
Hancz Dora	*Macrophage and hepatic stellate cell phenotypes are affected by longitudinal treatment with Zalfermin in a model of Metabolic Dysfunction-Associated Steatohepatitis*
Hansen Sandra	*Species-specific anti-fibrotic effects of bile acids in human and mouse precision-cut kidney slices*
Hart kevin	*Fab5 macrophage expression of GPNMB promote fibrosis across organs* *Myeloid cells contribute to bystander CD8 T-cell accumulation in MASH and are sufficient for fibrosis* *Cross regulatory cytokine networks and rebound inflammation in fibrotic disease* *Leveraging Single Cell Genomics to Resolve Macrophage Heterogeneity across Tissue and Disease: Mapping in vitro to in vivo Profiles*
Hassan Ghada	*The dual role of neutrophils during liver injury*
Henderson Neil	*Using single cell and spatial genomics to decode human liver regeneration and repair*
Hendler Roni	*In Vitro Liver Tissue Engineering with Coralline Biomaterial*
Herro Rana	*Targeting Fibrosis to Change Cancer Outcomes* *Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis*
Hinchcliff Monique	*Starts and stops: Adipocytes in tissue repair and fibrosis*
Hinz Boris	*Mechanically regulated transcription factors balance between regenerative and fibrotic cell memory* *The stressed relationship between macrophages and fibroblasts*
Hoffman-Vold Anna-Maria	*Characterization of monocytes in systemic sclerosis: linking gene signatures to skin fibrosis trajectories*
Hofman Astrid	*Characterization of monocytes in systemic sclerosis: linking gene signatures to skin fibrosis trajectories*
Horsley Valerie	*Starts and stops: Adipocytes in tissue repair and fibrosis*
Inverso Donato	*Spatially Resolved Phosphoproteomic Reveals Mechanistic Insights into Vascular Zonation and Liver Regeneration.*
Ivanov Andrei	*Cdc42 small GTPase is a novel regulator of the fibrogenic activation of human intestinal myofibroblasts*
Jenkins Gisli	*A Scar is Born: The molecular pathology of pulmonary fibrosis*
Kaczmarek Monika	*How Th2 specific cytokines: interleukin (IL)-4 and IL-13 affect cellular metabolism and reactive oxygen species production in mare endometrial fibroblasts?* *Understanding the effect of hypoxia on the interactions between endometrial fibroblasts and macrophages in equine endometrosis – in vitro study* *Involvement of interleukin 17 in mare endometrial fibrosis*
Kado Saki	*Construction and performance evaluation of CTGF measurement system for IPF biomarker candidate*
Kakavouli Gesthimani	*The endothelial-specific receptor Robo4 protects against metabolic dysfunction-associated steatotic liver disease and progression to liver fibrosis*
Kapel Benedicte	*Macrophage and hepatic stellate cell phenotypes are affected by longitudinal treatment with Zalfermin in a model of Metabolic Dysfunction-Associated Steatohepatitis*
Karras Alexandre	*PPARγ Repression Of Renal Tubular Epithelial Cell dysmetabolism to Treat Fibrosis*
Kato Elizabeth	*Targeting Fibrosis to Change Cancer Outcomes* *Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis*
Khedr Omar	*The dual role of neutrophils during liver injury*
Kisseleva Tatiana	*IL-17 signaling regulates TNF-TNFR1 responses in steatotic hepatocytes in mice.*
Knitlova Jarmila	*Alleviating fibrosis in the stiff, contracted tissue of clubfoot: A way to facilitate faster corrective therapy in relapsed patients?* *Proteomic comparison of contracted tissues of Dupuytren's disease with palmar fascia* *3D scaffold-based in vitro model of Dupuytren´s disease*
Kojima Masaaki	*Construction and performance evaluation of CTGF measurement system for IPF biomarker candidate*
Kramann Rafael	*Common mechanisms of fibrosis in kidney and heart*
Kravarik Kellie	*Myeloid cells contribute to bystander CD8 T-cell accumulation in MASH and are sufficient for fibrosis* *Leveraging Single Cell Genomics to Resolve Macrophage Heterogeneity across Tissue and Disease: Mapping in vitro to in vivo Profiles*
Kronenberg Mitchell	*Targeting Fibrosis to Change Cancer Outcomes*
Lafyatis Bob	*Single nucleotide resolution of altered transcription factor binding in profibrotic macrophages from patients with interstitial lung disease*
Larrue Romain	*Role and Therapeutic Potential of the Long Non-Coding RNA DNM3OS in Liver Fibrosis*
Leask Andrew	*CCN3-Derived Peptide BLR-200 has Anti-Fibrotic Properties in Systemic Sclerosis*
Lech Matthew	*Leveraging Single Cell Genomics to Resolve Macrophage Heterogeneity across Tissue and Disease: Mapping in vitro to in vivo Profiles*
Lefebvre Bruno	*Role and Therapeutic Potential of the Long Non-Coding RNA DNM3OS in Liver Fibrosis*
Legaki Aigli-Ioanna	*The endothelial-specific receptor Robo4 protects against metabolic dysfunction-associated steatotic liver disease and progression to liver fibrosis*
Lembicz Paul	*Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis* *Targeting Fibrosis to Change Cancer Outcomes*
Lenoir Olivia	*PPARγ Repression Of Renal Tubular Epithelial Cell dysmetabolism to Treat Fibrosis*
Li Lumeng	*Characterization of monocytes in systemic sclerosis: linking gene signatures to skin fibrosis trajectories*
Logan David	*Leveraging Single Cell Genomics to Resolve Macrophage Heterogeneity across Tissue and Disease: Mapping in vitro to in vivo Profiles*
Maali Yousef	*The dual role of neutrophils during liver injury*
Mann Jelena	*Using Human Liver Slices to Assess Efficacy of New Compounds and Illuminate the Biology of Fibrosis*
Marino-Melendez Armando	*Cdc42 small GTPase is a novel regulator of the fibrogenic activation of human intestinal myofibroblasts*
Martin Paul	*Investigation inflammation and skin repair in various model organisms*
Martin-Saiz Lucia	*PPARγ Repression Of Renal Tubular Epithelial Cell dysmetabolism to Treat Fibrosis*
Martino Roxanne	*Leveraging Single Cell Genomics to Resolve Macrophage Heterogeneity across Tissue and Disease: Mapping in vitro to in vivo Profiles*
Mayo Avi	*Cold and hot fibrosis define clinically distinct cardiac injuries*
McKinsey Timothy A.	*Phenotypic Screening, Machine Learning and New Therapeutic Targets for Cardiac Fibrosis*
McMahon James	*Myeloid cells contribute to bystander CD8 T-cell accumulation in MASH and are sufficient for fibrosis*
Medina Cesar	*Macrophage and hepatic stellate cell phenotypes are affected by longitudinal treatment with Zalfermin in a model of Metabolic Dysfunction-Associated Steatohepatitis*
Meers Caroline	*AGMB-101, a full agonistic antibody of MET, achieves deep suppression of liver fibrosis through a pleiotropic mechanism of action*
Metz Claudia	*Attenuation of Fibrosis in Folic Acid-Induced Kidney Injury by Endogenous Gal-8*
Michieli Paolo	*AGMB-101, a full agonistic antibody of MET, achieves deep suppression of liver fibrosis through a pleiotropic mechanism of action*
Miller Andrew	*Mechanically regulated transcription factors balance between regenerative and fibrotic cell memory*
Mitsi Maria	*3DPROFIB: an in vitro 3D assay in synthetic hydrogels to quantify extracellular matrix remodeling in fibrosis*
Miyara Shoval	*Cold and hot fibrosis define clinically distinct cardiac injuries*
Molcan Tomasz	*Understanding the effect of hypoxia on the interactions between endometrial fibroblasts and macrophages in equine endometrosis – in vitro study* *Involvement of interleukin 17 in mare endometrial fibrosis*
Morello Virginia	*AGMB-101, a full agonistic antibody of MET, achieves deep suppression of liver fibrosis through a pleiotropic mechanism of action*
Moustakas Ioannis	*The endothelial-specific receptor Robo4 protects against metabolic dysfunction-associated steatotic liver disease and progression to liver fibrosis*
Much Laura	*Characterization of monocytes in systemic sclerosis: linking gene signatures to skin fibrosis trajectories*
Mutsaers Henricus	*Species-specific anti-fibrotic effects of bile acids in human and mouse precision-cut kidney slices*
Myszczyński Kamil	*How Th2 specific cytokines: interleukin (IL)-4 and IL-13 affect cellular metabolism and reactive oxygen species production in mare endometrial fibroblasts?*
Nakagawa Yuichi	*Construction and performance evaluation of CTGF measurement system for IPF biomarker candidate*
Nguyen Xinh-Xinh	*Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis*
Noble Paul	*Anger Management: Targeting Invasive Fibroblasts in Progressive Pulmonary Fibrosis (It’s more than matrix production)*
Norlin Jenny	*Macrophage and hepatic stellate cell phenotypes are affected by longitudinal treatment with Zalfermin in a model of Metabolic Dysfunction-Associated Steatohepatitis*
Novotny Tomas	*Alleviating fibrosis in the stiff, contracted tissue of clubfoot: A way to facilitate faster corrective therapy in relapsed patients?* *Proteomic comparison of contracted tissues of Dupuytren's disease with palmar fascia*
Nørregaard Rikke	*Species-specific anti-fibrotic effects of bile acids in human and mouse precision-cut kidney slices*
Oldenburger Anouk	*Macrophage and hepatic stellate cell phenotypes are affected by longitudinal treatment with Zalfermin in a model of Metabolic Dysfunction-Associated Steatohepatitis*
Olinga Peter	*Precision-Cut Tissue Slices: A Cutting-Edge Tool for Studying and Advancing the Treatment of Fibrotic Diseases*
Ostadal Martin	*Alleviating fibrosis in the stiff, contracted tissue of clubfoot: A way to facilitate faster corrective therapy in relapsed patients?* *Proteomic comparison of contracted tissues of Dupuytren's disease with palmar fascia*
Pacheco Rodrigo	*Attenuation of Fibrosis in Folic Acid-Induced Kidney Injury by Endogenous Gal-8*
Pachera Elena	*Characterization of monocytes in systemic sclerosis: linking gene signatures to skin fibrosis trajectories*
Papadopoulos Grigorios	*The endothelial-specific receptor Robo4 protects against metabolic dysfunction-associated steatotic liver disease and progression to liver fibrosis*
Parmentier Fleur	*Deciphering stellate cell quiescence program*
Pérez-Molina Francisca	*Attenuation of Fibrosis in Folic Acid-Induced Kidney Injury by Endogenous Gal-8*
Perez-Moreno Elisa	*Attenuation of Fibrosis in Folic Acid-Induced Kidney Injury by Endogenous Gal-8*
Perrais Michael	*Role and Therapeutic Potential of the Long Non-Coding RNA DNM3OS in Liver Fibrosis*
Pfister Dominik	*Macrophage and hepatic stellate cell phenotypes are affected by longitudinal treatment with Zalfermin in a model of Metabolic Dysfunction-Associated Steatohepatitis*
Pottier Nicolas	*Role and Therapeutic Potential of the Long Non-Coding RNA DNM3OS in Liver Fibrosis*
Prado Carolina	*Attenuation of Fibrosis in Folic Acid-Induced Kidney Injury by Endogenous Gal-8*
Rebelo Sofia	*Modeling cardiac fibrosis in vitro: impact of monocyte-derived macrophages on cardiac fibroblast activation*
Resmini Lea	*PPARγ Repression Of Renal Tubular Epithelial Cell dysmetabolism to Treat Fibrosis*
Rieder Florian	*Cdc42 small GTPase is a novel regulator of the fibrogenic activation of human intestinal myofibroblasts*
Sadowska Agnieszka	*How Th2 specific cytokines: interleukin (IL)-4 and IL-13 affect cellular metabolism and reactive oxygen species production in mare endometrial fibroblasts?* *Involvement of interleukin 17 in mare endometrial fibrosis*
Saez Javiera	*Attenuation of Fibrosis in Folic Acid-Induced Kidney Injury by Endogenous Gal-8*
Sanders Yan	*Epigenetic control of extracellular matrix genes by histone acetyltransferase p300*
Saqib Uzma	*The BiST of Burden: Harnessing biased STING agonists to enhance the resolution of inflammation and limit tissue fibrosis*
sattanino Damiana	*AGMB-101, a full agonistic antibody of MET, achieves deep suppression of liver fibrosis through a pleiotropic mechanism of action*
Schif-Zuck Sagie	*The BiST of Burden: Harnessing biased STING agonists to enhance the resolution of inflammation and limit tissue fibrosis*
Schlerman Franklin	*Fab5 macrophage expression of GPNMB promote fibrosis across organs*
Schneider-Kramann Rebekka	*Mapping fibrosis progression and reversal in the bone marrow*
Schwabe Robert	*Regulation of liver zonation, metabolism, injury and regeneration by hepatic stellate cells*
Serra Margarida	*Modeling cardiac fibrosis in vitro: impact of monocyte-derived macrophages on cardiac fibroblast activation*
Shoukry Naglaa	*The dual role of neutrophils during liver injury*
Shyer Justin	*The origin and TGFb dependency of fibrosis and inflammation associated fibroblasts*
Sierra Charlotte	*PPARγ Repression Of Renal Tubular Epithelial Cell dysmetabolism to Treat Fibrosis*
Simão Daniel	*Modeling cardiac fibrosis in vitro: impact of monocyte-derived macrophages on cardiac fibroblast activation*
Simona Benjamin	*3DPROFIB: an in vitro 3D assay in synthetic hydrogels to quantify extracellular matrix remodeling in fibrosis*
Skarżyński Dariusz	*Exploring the impact of MΦ(IFNγ/LPS) and MΦ(IL-4/IL-13) on equine endometrial transcriptome and ECM-related genes: insights from an in vivo study*
Słyszewska Magda	*Exploring the impact of MΦ(IFNγ/LPS) and MΦ(IL-4/IL-13) on equine endometrial transcriptome and ECM-related genes: insights from an in vivo study*
Soza Andrea	*Attenuation of Fibrosis in Folic Acid-Induced Kidney Injury by Endogenous Gal-8*
Stachon Roman	*3D scaffold-based in vitro model of Dupuytren´s disease*
Steele Hope	*Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis* *Targeting Fibrosis to Change Cancer Outcomes*
Suchoski Therese	*Targeting Fibrosis to Change Cancer Outcomes*
Suchowski Therese	*Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis*
Sugino Shiro	*Construction and performance evaluation of CTGF measurement system for IPF biomarker candidate*
Szóstek-Mioduchowska Anna	*Exploring the impact of MΦ(IFNγ/LPS) and MΦ(IL-4/IL-13) on equine endometrial transcriptome and ECM-related genes: insights from an in vivo study* *How Th2 specific cytokines: interleukin (IL)-4 and IL-13 affect cellular metabolism and reactive oxygen species production in mare endometrial fibroblasts?* *Understanding the effect of hypoxia on the interactions between endometrial fibroblasts and macrophages in equine endometrosis – in vitro study* *Involvement of interleukin 17 in mare endometrial fibrosis*
Teixeira Geoffrey	*Targeting Claudin-1 as a novel therapeutic approach to reverse organ fibrosis*
Tharaux Pierre-Louis	*PPARγ Repression Of Renal Tubular Epithelial Cell dysmetabolism to Treat Fibrosis* Mineralocorticoid receptor inhibition in parietal epithelial cells commands inflammatory and motile phenotype and prevents focal segmental glomerulosclerosis and crescentic glomerulonephritis. A novel mechanistic paradigm.
Tobolski Dawid	*Exploring the impact of MΦ(IFNγ/LPS) and MΦ(IL-4/IL-13) on equine endometrial transcriptome and ECM-related genes: insights from an in vivo study* *Understanding the effect of hypoxia on the interactions between endometrial fibroblasts and macrophages in equine endometrosis – in vitro study*
Toledo Tomás	*Attenuation of Fibrosis in Folic Acid-Induced Kidney Injury by Endogenous Gal-8*
Tzahor Eldad	*Cold and hot fibrosis define clinically distinct cardiac injuries*
van Dekken Rianne	*Species-specific anti-fibrotic effects of bile acids in human and mouse precision-cut kidney slices*
Van der Hauwaert Cynthia	*Role and Therapeutic Potential of the Long Non-Coding RNA DNM3OS in Liver Fibrosis*
Van Kaem Tim	*A New Frontier in IBD - Towards the prevention of structural bowel damage in Crohn’s disease*
Van Roy Maarten	*AGMB-101, a full agonistic antibody of MET, achieves deep suppression of liver fibrosis through a pleiotropic mechanism of action*
Vanneste Bavo	*Deciphering stellate cell quiescence program*
Veidal Sanne	*Macrophage and hepatic stellate cell phenotypes are affected by longitudinal treatment with Zalfermin in a model of Metabolic Dysfunction-Associated Steatohepatitis*
Velliou Rallia-Iliana	*The endothelial-specific receptor Robo4 protects against metabolic dysfunction-associated steatotic liver disease and progression to liver fibrosis*
Vondrasek David	*Alleviating fibrosis in the stiff, contracted tissue of clubfoot: A way to facilitate faster corrective therapy in relapsed patients?*
Wadsworth Marc	*Fab5 macrophage expression of GPNMB promote fibrosis across organs*
Wadsworth II Marc	*Leveraging Single Cell Genomics to Resolve Macrophage Heterogeneity across Tissue and Disease: Mapping in vitro to in vivo Profiles* *Myeloid cells contribute to bystander CD8 T-cell accumulation in MASH and are sufficient for fibrosis*
Wagner Sophie	*Characterization of monocytes in systemic sclerosis: linking gene signatures to skin fibrosis trajectories* *Deciphering stellate cell quiescence program*
Walther Lise	*Macrophage and hepatic stellate cell phenotypes are affected by longitudinal treatment with Zalfermin in a model of Metabolic Dysfunction-Associated Steatohepatitis*
Wang Yan	*Cdc42 small GTPase is a novel regulator of the fibrogenic activation of human intestinal myofibroblasts* *Fab5 macrophage expression of GPNMB promote fibrosis across organs*
Watanabe Mitsuo	*Construction and performance evaluation of CTGF measurement system for IPF biomarker candidate*
Weiss Orly	*In Vitro Liver Tissue Engineering with Coralline Biomaterial*
Werner Sabine	*Stromal-epithelial communication in tissue repair and cancer*
Willicut Ashley	*Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis*
Wójtowicz Anna	*How Th2 specific cytokines: interleukin (IL)-4 and IL-13 affect cellular metabolism and reactive oxygen species production in mare endometrial fibroblasts?* *Involvement of interleukin 17 in mare endometrial fibrosis*
Wynn Thomas	*Fab5 macrophage expression of GPNMB promote fibrosis across organs* *Myeloid cells contribute to bystander CD8 T-cell accumulation in MASH and are sufficient for fibrosis* *Leveraging Single Cell Genomics to Resolve Macrophage Heterogeneity across Tissue and Disease: Mapping in vitro to in vivo Profiles*
Yaworsky Paul	*A neutralizing antibody to EphrinB2 suppresses fibrosis in preclinical in vitro and in vivo models*
Younesi Fereshteh	*Mechanically regulated transcription factors balance between regenerative and fibrotic cell memory*
Zafar Atif	*Cdc42 small GTPase is a novel regulator of the fibrogenic activation of human intestinal myofibroblasts*
Żebrowska Ewelina	*Understanding the effect of hypoxia on the interactions between endometrial fibroblasts and macrophages in equine endometrosis – in vitro study*
Zgheib Rima	*Targeting Fibrosis to Change Cancer Outcomes* *Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis*